December 07, 2018
Biophytis Announces One Oral Presentation and Two Poster Presentations at the 11th International Conference on Cachexia, Sarcopenia and Muscle Wasting. Read the Press Release
Biophytis Announces One Oral Presentation and Two Poster Presentations at the 11th International Conference on Cachexia, Sarcopenia and Muscle Wasting. Read the Press Release
Biophytis to Host Key Opinion Leader Meeting on the Biology of Aging and its Application in Neuromuscular Diseases. Read the Press Release
Interim results 2018 and perspective on activity. Read the Press Release
Biophytis obtains a €10 million loan with Kreos Capital. Read the Press Release
Biophytis Provides Enrollment Update in Its Phase 2b SARA-OBS and SARA-INT Studies of Sarconeos in Sarcopenia. Read the Press Release
BIOPHYTIS to Present at the H.C. Wainwright 20th Annual Global Investment Conference. Read the Press Release
Biophytis appoints a new Chief Medical Officer based in the USA. Read the Press Release
Results of the Extraordinary General Meeting held on June 4, 2018. Passing of all the resolutions. Read the Press Release
Biophytis receives favourable opinion from EMA for the Orphan Drug designation of Sarconeos in Duchenne Muscular Dystrophy (DMD). Read the Press Release